ANALISIS OPTIMALISASI MODAL KERJA PADA PERUSAHAAN FARMASI YANG TERCATAT DI BURSA EFEK INDONESIA
| Main Author: | SYAFRILIA, SITI |
|---|---|
| Format: | Thesis NonPeerReviewed Book |
| Bahasa: | eng |
| Terbitan: |
, 2012
|
| Subjects: | |
| Online Access: |
http://eprints.umm.ac.id/20067/1/jiptummpp-gdl-triyasfitr-30182-1-pendahul-n%20%281%29.pdf http://eprints.umm.ac.id/20067/2/jiptummpp-gdl-triyasfitr-30182-2-babi.pdf http://eprints.umm.ac.id/20067/3/jiptummpp-gdl-triyasfitr-30182-3-babii.pdf http://eprints.umm.ac.id/20067/ |
Daftar Isi:
- This study aims to determine the optimal working capital at the pharmaceutical company listed on the Indonesia Stock Exchange the period 2009 to 2010. Based on the background of the states combined pharmaceutical company Indonesia pojecting the national pharmaceutical market in 2012 increased 14-15 %. Increase in sales is directly proportional to the increase of real working capital, as happened in Tempo Scan sales increased 33 % and real working capital increased 13 % . Decline in sales is directly proportional to the real working capital reduction that occurred in the Taisho sales declined 27 % and the real working capital descreased 16 %. The results showed nine pharmaceutical companies working capital has not been optimal. In 2009, a total of five companies result MKR > MKO, which means the excess of real working capital of working capital or working capital of the real need to be reduced. The results of four pharmaceutical companies MKR < MKO which means a real shortage of working capital or working capital needs of real plus. In 2010, six companies result MKR > MKO, which means the excess of real working capital or working capital of the real need be reduced. Three pharmaceutical companies result MKR < MKO which means a real shortage of working capital or working capital needs of real plus.